Related references
Note: Only part of the references are listed.Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
Simone de Vries et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Classical Hodgkin lymphoma
Pauline Brice et al.
LANCET (2021)
Molecular biology of Hodgkin lymphoma
Marc A. Weniger et al.
LEUKEMIA (2021)
Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis
Jie Gao et al.
BMC CANCER (2021)
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma
David J. Cutter et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Cardiovascular effects of Hodgkin's lymphoma: a review of literature
Aasems Jacob et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management
Stephen M. Ansell
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Cardiovascular Disease Risk After Treatment-Induced Premature Ovarian Insufficiency in Female Survivors of Hodgkin Lymphoma
Inge M. Krul et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Excess mortality among 10-year survivors of classical Hodgkin lymphoma in adolescents and young adults
Ana C. Xavier et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines
Frederika A. van Nimwegen et al.
BLOOD (2017)
Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain
Miranda M. Fidler et al.
CIRCULATION (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age The Teenage and Young Adult Cancer Survivor Study
Katherine E. Henson et al.
CIRCULATION (2016)
Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study
Nickhill Bhakta et al.
LANCET ONCOLOGY (2016)
Cardiac Mortality in Children and Adolescents with Hodgkin's Lymphoma: A Surveillance, Epidemiology and End Results Analysis
Arya Amini et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2016)
Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma
Sadeer G. Al-Kindi et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Impact of Cardiovascular Counseling and Screening in Hodgkin Lymphoma Survivors
Laurien A. Daniels et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma
M. V. Maraldo et al.
ANNALS OF ONCOLOGY (2013)
Temporal Trends in Mortality From Diseases of the Circulatory System After Treatment for Hodgkin Lymphoma: A Population-Based Cohort Study in Sweden (1973 to 2006)
Sandra Eloranta et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
Sharon M. Castellino et al.
BLOOD (2011)
Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult Hodgkin lymphoma patient
David J. Straus
THERAPEUTIC ADVANCES IN HEMATOLOGY (2011)
Mortality is persistently increased in Hodgkin's lymphoma survivors
Cecilie E. Kiserud et al.
EUROPEAN JOURNAL OF CANCER (2010)
Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors-Retrospective cohort analyses and a concept for prospective intervention
Anne Andersson et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Long-term events in adult patients with clinical stage IA-IIa nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin,vinblastine, and dacarbazine and adjuvant radiotherapy: A single-institution 15-year follow-up
Ercole Brusamolino et al.
CLINICAL CANCER RESEARCH (2006)
Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy
MC Hull et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Long-term cause-specific mortality of patients treated for Hodgkin's disease
BMP Aleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger
AK Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Late mortality experience in five-year survivors of childhood and adolescent cancer: The childhood cancer survivor study
AC Mertens et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)